Inactive Instrument

Analyst Reco. Pixarbio Corp Other OTC

Equities

End-of-day quote Other OTC Other stock markets
- ^USD	-

2018	PixarBio Corporation Clarifies Pathways to FDA Approval for NR14 to Treat “Trigeminal Neuralgia” and Post-Surgical Pain	CI
2018	Pixarbio Corporation Announces the Removal of Katrin Holzhaus as Chief Administration Officer and Corporate Secretary of the Company	CI

No results for this search